Advertisement

Drugs & Therapy Perspectives

, Volume 21, Issue 9, pp 7–9 | Cite as

Bacterial pericarditis requires antibacterial therapy tailored to the causative organism and patient

Disease Management

References

  1. 1.
    Pankuweit S, Ristić AD, Seferović PM et al. Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs 2005; 5(2): 103–12PubMedCrossRefGoogle Scholar
  2. 2.
    Rubin RH, Moellering Jr RC. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med 1975; 59(1): 68–78PubMedCrossRefGoogle Scholar
  3. 3.
    Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med 1977; 63: 666–73PubMedCrossRefGoogle Scholar
  4. 4.
    Keersmaekers T, Elshot SR, Sergeant PT. Primary bacterial pericarditis. Acta Cardiol 2002; 57(5): 387–9PubMedCrossRefGoogle Scholar
  5. 5.
    Spodick DH. Infectious pericarditis. In: Spodick DH, editor. The pericardium: a comprehensive textbook. New York: Marcel Dekker, 1997: 260–90Google Scholar
  6. 6.
    Brook I. Pericarditis due to anaerobic bacteria. Cardiology 2002; 97(2): 55–8PubMedCrossRefGoogle Scholar
  7. 7.
    Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, et al. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol 1993; 22: 1661–5PubMedCrossRefGoogle Scholar
  8. 8.
    Miller WI, Osborn MJ, Sinak LJ, et al. Pyopneumopericardium attributed to an esophagopericardial fistula: report of a survivor and review of the literature. Mayo Clin Proc 1991; 66: 1041–5PubMedCrossRefGoogle Scholar
  9. 9.
    Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56: 623–30PubMedCrossRefGoogle Scholar
  10. 10.
    Fowler NO. Tuberculous pericarditis. JAMA 1991; 266(1): 99–103PubMedCrossRefGoogle Scholar
  11. 11.
    Goodman LJ. Purulent pericarditis. Curr Treat Options Cardiovasc Med 2000; 2(4): 343–50PubMedCrossRefGoogle Scholar
  12. 12.
    Martineau AR, Beeching NJ, Nye FJ, et al. Serum and pericardial fluid bactericidal assays in a patient with staphylococcal pericarditis. J Infect 2001; 43(2): 158–9PubMedCrossRefGoogle Scholar
  13. 13.
    Scheid WM, Sande MA. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandel, Douglas and Bennett’s principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 740–56Google Scholar
  14. 14.
    Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Recomm Rep 1994; 43(RR13): 1–132Google Scholar
  15. 15.
    Mayosi BM, Ntsekhe M, Volmink JA, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002; (4): CD000526Google Scholar
  16. 16.
    Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998; 47(RR-20): 1–51Google Scholar

Copyright information

© Adis Data Information BV 2005

Personalised recommendations